Private equity firm Apiary Capital has completed its investment into life sciences performance marketing and specialist ...

BeiGene has announced that its Tevimbra (tislelizumab) has been approved by the European Commission (EC) as part of a ...

Gene therapy has the potential to change lives, slowing or stopping disease progression or even correcting symptoms entirely, ...

The US Food and Drug Administration (FDA) has announced that all its centres will operate on a common generative artificial ...

AstraZeneca (AZ) and Daiichi Sankyo have shared positive results from a late-stage study of their HER2-directed antibody drug ...

Tiziana Life Sciences has announced promising results from an open-label study of its investigational multiple sclerosis (MS) ...

The Weber Shandwick Collective (TWSC) has announced the appointment of Lucie Harper as president of Health, UK. Harper brings ...

Eli Lilly will be licensing Alchemab Therapeutics’ preclinical programme for amyotrophic lateral sclerosis (ALS) and other ...

Inizio Evoke has appointed Tristen George and Kevin Kaniuga as executive creative directors in a move aimed at “further strengthening” the agency’s creative leadership. George and Kaniuga both hold ...

AstraZeneca (AZ) has announced that its Bruton’s tyrosine kinase (BTK) inhibitor Calquence (acalabrutinib) has been approved ...

AZ’s triple-combination therapy is already approved under the brand names Breztri Aerosphere and Trixeo Aerosphere to treat ...

Connected patches can be used to monitor vital patient parameters in real time, including heart rate, oxygen saturation, ...